Apr 23, 2024
In the ever-evolving landscape of life sciences and healthcare, regulatory intelligence (RI) and pharmacovigilance (PV) play critical roles.
Mar 22, 2024
In the fast-evolving landscape of the medical device industry, harnessing the power of Artificial Intelligence (AI) is not just advantageous but essential for maintaining regulatory excellence.
Mar 15, 2024
Celegence, led by Sonia Veluchamy, is proud to announce that as of February 16, 2024, we are re-certified by the National Minority Supplier Development Council (NMSDC) as a Minority Business Enterprise (MBE) for the second consecutive year.